RCUS Arcus Biosciences Inc.

8.33
+0.23  (+3%)
Previous Close 8.1
Open 8.21
Price To Book 1.67
Market Cap 370,976,842
Shares 44,535,035
Volume 176,413
Short Ratio 8.99
Av. Daily Volume 196,529

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 dose-expansion cohort to be initiated mid-2019.
AB122
Healthy volunteers
Phase 1 dose escalation data due 2H 2019.
AB928 + Doxil
Triple negative breast cancer (TNBC) and ovarian cancer
Data from dose-escalation cohorts due 2H 2019.
AB928 + mFOLFOX
Colorectal Cancer
Phase 1 initial data presented at ASCO June 1, 2019.
AB928 + AB122
Solid tumors
Phase 1 initial data due 2H 2019.
AB154 + AB122
Solid tumors
Phase 1 safety data due 2H 2019.
AB680
Health volunteers

Latest News

  1. If You Had Bought Arcus Biosciences (NYSE:RCUS) Stock A Year Ago, You'd Be Sitting On A 30% Loss, Today
  2. The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO
  3. Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer
  4. Arcus Biosciences to Provide a Mid-Year Update on Clinical and Preclinical Programs
  5. Arcus Biosciences Inc (RCUS) CEO Terry J Rosen Bought $172,382 of Shares
  6. Arcus Biosciences to Present Preliminary Data from the Ongoing Phase 1 Dose-Escalation Trials of AB928 in Combination with Chemotherapy or AB122 at the 2019 ASCO Annual Meeting
  7. Arcus Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
  8. Is Arcus Biosciences, Inc. (RCUS) A Good Stock To Buy?
  9. Infinity (INFI) Earnings and Sales Miss Estimates in Q1
  10. Trade Anxieties Return with a Vengeance
  11. Arcus Biosciences Announces First Quarter 2019 Financial Results and Recent Corporate Updates
  12. Arcus Biosciences Appoints William Grossman, M.D., Ph.D., Chief Medical Officer
  13. Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122
  14. Arcus (RCUS) to Report Q1 Earnings: What's in the Cards?
  15. Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised
  16. What Kind Of Shareholders Own Arcus Biosciences, Inc. (NYSE:RCUS)?
  17. Arcus Biosciences, Inc. (RCUS) Shares March Higher, Can It Continue?
  18. Arcus Biosciences Appoints Rekha Hemrajani as Chief Operating and Financial Officer
  19. Infinity Inks Deal With Roche for Phase II Study of IPI-549
  20. Arcus Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Updates